- Article
Effectiveness and Safety of Molecular-Targeted Therapy after Nivolumab Plus Ipilimumab for Advanced or Metastatic Renal Cell Carcinoma: A Multicenter, Retrospective Cohort Study
- Koji Iinuma,
- Koji Kameyama,
- Tomoki Taniguchi,
- Kei Kawada,
- Takashi Ishida,
- Kimiaki Takagi,
- Shingo Nagai,
- Torai Enomoto,
- Masayuki Tomioka and
- Takuya Koie
- + 4 authors
This study aimed to evaluate the effectiveness and safety of molecular-targeted therapies (MTTs) after the discontinuation of nivolumab and ipilimumab (NIVO+IPI) combination therapy in patients who had been diagnosed with advanced/metastatic renal ce...